Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Stadler R, Quaglino P, Woei-A-Jin FJSH, Dummer R, Mitteldorf C, Papadavid E, Ortiz Romero PL, Guenova E, Abe R, Cowan R, Bagot M, Dalle S, Fujimura T, Gambichler T, Morris S, Wehkamp U, Terheyden P, Cozzio A, Dippel E, Alberti-Violetti S, Romejko-Jarosinska J, Wozniacka A, González Barca E, Pujol Vallverdu R, Ramelyte E, Bechter O, Suzuki K, Knobler R, Danhauser-Riedl S, Scarisbrick J, RESMAIN Investigators

Open source

DOI: 10.1016/s2352-3026(25)00322-9
Published: 2026 Feb
Container: The Lancet. Haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-25-00322-9,
  title = {Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.},
  author = {Stadler R and Quaglino P and Woei-A-Jin FJSH and Dummer R and Mitteldorf C and Papadavid E and Ortiz Romero PL and Guenova E and Abe R and Cowan R and Bagot M and Dalle S and Fujimura T and Gambichler T and Morris S and Wehkamp U and Terheyden P and Cozzio A and Dippel E and Alberti-Violetti S and Romejko-Jarosinska J and Wozniacka A and González Barca E and Pujol Vallverdu R and Ramelyte E and Bechter O and Suzuki K and Knobler R and Danhauser-Riedl S and Scarisbrick J and RESMAIN Investigators},
  year = {2026},
  journal = {The Lancet. Haematology},
  doi = {10.1016/s2352-3026(25)00322-9},
  url = {https://doi.org/10.1016/s2352-3026(25)00322-9}
}

RIS

TY  - JOUR
TI  - Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
AU  - Stadler R
AU  - Quaglino P
AU  - Woei-A-Jin FJSH
AU  - Dummer R
AU  - Mitteldorf C
AU  - Papadavid E
AU  - Ortiz Romero PL
AU  - Guenova E
AU  - Abe R
AU  - Cowan R
AU  - Bagot M
AU  - Dalle S
AU  - Fujimura T
AU  - Gambichler T
AU  - Morris S
AU  - Wehkamp U
AU  - Terheyden P
AU  - Cozzio A
AU  - Dippel E
AU  - Alberti-Violetti S
AU  - Romejko-Jarosinska J
AU  - Wozniacka A
AU  - González Barca E
AU  - Pujol Vallverdu R
AU  - Ramelyte E
AU  - Bechter O
AU  - Suzuki K
AU  - Knobler R
AU  - Danhauser-Riedl S
AU  - Scarisbrick J
AU  - RESMAIN Investigators
PY  - 2026
JO  - The Lancet. Haematology
DO  - 10.1016/s2352-3026(25)00322-9
UR  - https://doi.org/10.1016/s2352-3026(25)00322-9
ER  -

APA

R, S., P, Q., FJSH, W., R, D., C, M., E, P., PL, O. R., E, G., R, A., R, C., M, B., S, D., T, F., T, G., S, M., U, W., P, T., A, C., E, D., S, A., J, R., A, W., E, G. B., R, P. V., E, R., O, B., K, S., R, K., S, D., J, S., & Investigators, R. (2026). Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.. The Lancet. Haematology. https://doi.org/10.1016/s2352-3026(25)00322-9

Source records

pubmed · retrieved 2026-09-26T04:48:27.653Z